Literature DB >> 16026789

Age-related decrease in high-density lipoproteins antioxidant activity is due to an alteration in the PON1's free sulfhydryl groups.

Leila Jaouad1, Chantal de Guise, Hicham Berrougui, Martin Cloutier, Maxim Isabelle, Tamas Fulop, Hélène Payette, Abdelouahed Khalil.   

Abstract

The aim of this study was to evaluate the antioxidant activity of HDL with aging and to investigate the implication of PON1 in this process. The study involved 54 healthy subjects distributed in two age groups, young (20-25 years) and elderly (65-85 years). Lipid peroxidation was induced by *OH and O2*- oxygen free radicals produced by gamma-radiolysis of water. LDL oxidation was followed by the measurement of conjugated diene (CD), lipid peroxide (LP) and malondialdehyde (MDA) formation. PON1 was purified separately from young (Y-PON1) and elderly subjects (E-PON1). PON1 activity and structure was followed by measurement of PON1 paraoxonase (p.ase) activity, titration of the SH groups, and electrophoretic mobility by SDS-PAGE. Our results show a significant decrease in the HDL antioxidant activity: percentage of protection against CD formation=27.70% (p<0.01) for E-HDL versus 73.08% (p<0.001) for Y-HDL. Moreover, E-PON1 showed a lower antioxidant activity when compared to Y-PON1 47.08% versus 78.14%, respectively (p<0.0001). Exposition of PON1 to *OH and O2*- oxygen free radicals induced a significant decrease in PON1 p.ase activity as well as a reduction in the number of PON1's free sulfhydryl groups. Moreover, our results show a close association between PON1's free sulfhydryl groups and its capacity to protect LDL against lipid peroxidation. There was a significant decrease in the number of free sulfhydryls between Y-PON1 and E-PON1 with respect to cysteine-284 amino acid residues (p<0.0092).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16026789     DOI: 10.1016/j.atherosclerosis.2005.06.012

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  33 in total

1.  Methylmercury exposure, PON1 gene variants and serum paraoxonase activity in Eastern James Bay Cree adults.

Authors:  Olivia Drescher; Eric Dewailly; Caroline Diorio; Nathalie Ouellet; Elhadji Anassour Laouan Sidi; Belkacem Abdous; Beatriz Valera; Pierre Ayotte
Journal:  J Expo Sci Environ Epidemiol       Date:  2014-01-22       Impact factor: 5.563

Review 2.  The human paraoxonase gene cluster as a target in the treatment of atherosclerosis.

Authors:  Zhi-Gang She; Hou-Zao Chen; Yunfei Yan; Hongliang Li; De-Pei Liu
Journal:  Antioxid Redox Signal       Date:  2011-10-18       Impact factor: 8.401

3.  Age is positively associated with high-density lipoprotein cholesterol among African Americans in cross-sectional analysis: the Jackson Heart Study.

Authors:  Jane L Harman; Michael E Griswold; Neal O Jeffries; Anne E Sumner; Daniel F Sarpong; Ermeg L Akylbekova; Evelyn R Walker; Sharon B Wyatt; Herman A Taylor
Journal:  J Clin Lipidol       Date:  2011-03-02       Impact factor: 4.766

Review 4.  Paraoxonases as potential antibiofilm agents: their relationship with quorum-sensing signals in Gram-negative bacteria.

Authors:  Jordi Camps; Isabel Pujol; Frederic Ballester; Jorge Joven; Josep M Simó
Journal:  Antimicrob Agents Chemother       Date:  2011-01-03       Impact factor: 5.191

Review 5.  Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles.

Authors:  Mike Mackness; Bharti Mackness
Journal:  Gene       Date:  2015-05-09       Impact factor: 3.688

6.  Paraoxonase 2 decreases renal reactive oxygen species production, lowers blood pressure, and mediates dopamine D2 receptor-induced inhibition of NADPH oxidase.

Authors:  Yu Yang; Yanrong Zhang; Santiago Cuevas; Van Anthony Villar; Crisanto Escano; Laureano D Asico; Peiying Yu; David K Grandy; Robin A Felder; Ines Armando; Pedro A Jose
Journal:  Free Radic Biol Med       Date:  2012-05-23       Impact factor: 7.376

7.  Relation of plasma protein oxidation parameters and paraoxonase activity in the ageing population.

Authors:  Ufuk Cakatay; Refik Kayali; Hafize Uzun
Journal:  Clin Exp Med       Date:  2008-04-03       Impact factor: 3.984

8.  Is elevated high-density lipoprotein cholesterol always good for coronary heart disease?

Authors:  Yuhua Sun; Yuejin Yang; Weidong Pei; Yongjian Wu; Jinglin Zhao
Journal:  Clin Cardiol       Date:  2007-11       Impact factor: 2.882

9.  Immunomodulatory role of high-density lipoproteins: impact on immunosenescence.

Authors:  Anis Larbi; Carl Fortin; Gilles Dupuis; Hicham Berrougui; Abdelouahed Khalil; Tamas Fulop
Journal:  Age (Dordr)       Date:  2014-09-13

10.  The common variant Q192R at the paraoxonase 1 (PON1) gene and its activity are responsible for a portion of the altered antioxidant status in type 2 diabetes.

Authors:  Mehryar Zargari; Fahimeh Sharafeddin; Abdolkarim Mahrooz; Ahad Alizadeh; Parisa Masoumi
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.